您好,欢迎访问中山大学肿瘤防治中心官方网站!
内部网 职工邮箱 图书馆 OA系统 医生门户 English
院士风采 首席专家 临床专家 科研学者 客座教授 人才名录
首页
  • 张玉晶

    职务:医院淋巴瘤和胃胰肿瘤单病种专家会诊组成员,放疗科二病区淋巴瘤、乳腺癌和胃胰肿瘤放射治疗组主诊教授。
    职称:主任医师,硕士研究生导师,中山大学长学制医学生(八年制)全程导师。
    专长:肿瘤放射治疗和综合治疗的临床工作及相关放射和分子生物学研究。特别擅长淋巴瘤、乳腺癌、胃癌和胰腺癌等消化道肿瘤以及软组织肉瘤的放射治疗及研究。
    一、基本情况
    职称:主任医师、硕士生导师 
    专家门诊时间: 周一下午(特需);周三下午
    专业特长:肿瘤放射治疗和综合治疗的临床工作及相关放射和分子生物学研究。特别擅长淋巴瘤、乳腺癌、胃癌和胰腺癌等消化道肿瘤以及软组织肉瘤的放射治疗及研究。

    二、学习及工作经历:
       2002-至今  中山大学肿瘤防治中心放射治疗科主治医师、副主任医师(2004)、主任医师(2010) 
      2010-2011  新疆医科大学肿瘤医院乳腺和胸腹放疗科副主任、援疆专家 
      2008-2009  Baylor医学院/得克萨斯儿童癌症中心血液和肿瘤学实验室博士后 
      2007-2008  得克萨斯大学M.D.安德森癌症中心放射肿瘤学部访问研究员 
      1999-2002  中国协和医科大学/中国医学科学院肿瘤医院放射肿瘤学博士研究生 
      1995-1999  山东大学齐鲁医院肿瘤中心放射治疗科住院医师、主治医师 
      1992-1995  山东医科大学普外科专业硕士研究生
      1986-1992  山东医科大学临床医学六年制英语医学班

      肿瘤放射治疗专业主任医师,硕士研究生导师

      张玉晶,肿瘤学博士,肿瘤放射治疗专业主任医师,硕士研究生导师。担任医院淋巴瘤、胃癌、胆胰肿瘤和软组织肉瘤单病种专家会诊组成员,放疗科二病区淋巴瘤和胃胆胰肿瘤放射治疗组主诊教授,普瘤组临床大PI。

    学术兼职:
      中国抗癌协会淋巴瘤专业委员会委员
      中国淋巴瘤放射治疗协作组(CLROG)成员
      国际淋巴瘤放射治疗协作组(ILROG)成员
      中国临床肿瘤学会(CSCO)胃癌专家委员会委员
      中国临床肿瘤学会(CSCO)原发性胃癌诊疗指南编写组成员
      广东省抗癌协会淋巴瘤专业委员会委员
      广东省抗癌协会胃癌专业委员会委员
      广东省抗癌协会胆道肿瘤专业委员会常务委员
      广州抗癌协会乳腺癌专业委员会委员
      广州抗癌协会淋巴瘤专业委员会 副主任委员
      广州抗癌协会脊柱肿瘤专业委员会 副主任委员
      广东省健康管理学会肿瘤防治专业委员会 常务委员
      广东省医师协会肿瘤多学科诊疗模式工作委员会 副主任委员
      新疆医科大学肿瘤学客座教授
      《中华放射肿瘤学杂志》第七届编委会通讯编委
      《中华肿瘤杂志》、《中华放射医学与防护杂志》《中华医学杂志英文版》、Hematological Oncology、International Journal of Radiation Oncology Biology and Physics、Journal of Cancer、Chinese Journal of Cancer等杂志审稿专家。

    学习和工作经历:
      2002-至今  中山大学肿瘤防治中心放疗科 主治医师、副主任医师(2004)、主任医师(2010)
      2010-2011  新疆医科大学肿瘤医院 放疗科副主任、援疆专家
      2008-2009  Baylor医学院/得克萨斯儿童癌症中心 博士后研究助理
      2007-2008  得克萨斯大学M.D.安德森癌症中心 访问学者
      1999-2002  中国协和医科大学/中国医学科学院肿瘤医院放射肿瘤学 博士研究生
      1995-1999  山东大学齐鲁医院肿瘤中心放疗科 住院医师、主治医师
      1992-1995  山东医科大学普外科专业 硕士研究生
      1986-1992  山东医科大学临床医学六年制英语医学班

    专业研究方向:
      从事肿瘤放射治疗20余年,专长于淋巴瘤、胃癌、胆胰肿瘤、乳腺癌和软组织肉瘤的放射治疗和综合治疗。
      其中,对结外鼻型NK/T细胞淋巴瘤和其他结外原发淋巴瘤的调强放疗,对胃癌的术前、术后放化疗以及胆胰肿瘤的调强放射治疗积累了较丰富的经验;对乳腺癌的放射治疗技术和早期乳腺癌的放疗指征有细致的研究。
      曾在著名的肿瘤学实验室从事肿瘤分子放射生物学和临床前实验研究,研究方向包括高LET射线的放射生物学、肿瘤干细胞放射敏感性调控以及个体肿瘤与正常组织放射敏感性的预测模型研究等。

    科研和基金项目:
    1.曾参加国家攀登计划(B)基金项目(85-45-01-1)“放射治疗及核医学先进方法技术的基础研究”,博士研究课题为“快中子的放射生物学研究及其在软组织肉瘤治疗中的应用”.
    2.广东省医学科研基金课题:EB病毒LMP1基因多态性与华南地区鼻型NK/T细胞淋巴瘤预后的关系(A2006232) 第1承担人,2006.9-2008.8,1万元。
    3.广东省科技计划项目:乳腺癌分子分型对腋窝淋巴结1~3个阳性早期患者局部复发风险的预测和辅助放射治疗指征的改进(2012B031800117),2013.1-2015.12,第1承担人,4万元。
    4.华南肿瘤学国家重点实验室开放课题:HLA-I基因甲基化与现将维、汉两民族三阴性乳腺癌发病和预后机制的研究(HN2014-02),2014.1-2015.12,合作单位第1承担者,5万元。
    5.国家自然科学基金面上项目:直肠癌术前同期放化疗后pCR 病例的筛选模型研究(批准号81071891),2010.1-2011.12,第2承担人,10万元。
    6.新疆维吾尔自治区科技厅科技援疆项目:锥形束CT在线校正技术和呼吸门控技术在胸部肿瘤放射治疗中的应用研究(201191159),2011.1-2013.12,合作单位第1承担人,30万元。
    7.新疆维吾尔自治区科技厅科技援疆项目:维吾尔族和汉族女性三阴性乳腺癌发生与抗原呈递元件(APM)表达调控的关系研究(201491178),2014.1-2016.12,合作单位第1承担人,30万元。
    8.中山大学临床科研5010计划项目:提高高危T细胞淋巴瘤治疗效果的随机多中心Ⅲ期临床研究,2008.1-2017.12,第3承担人,共计200万元。
    9.中山大学临床科研5010计划项目:术前放化疗联合手术及辅助化疗与术前化疗联合手术及辅助化疗治疗进展期胃癌的随机对照研究,2013.1-2022.12,第5承担人,共计200万元。

    近年发表的主要研究论著(*并列第一或通讯作者):
    1.Feng LL, et al. CT-based Vessel-guided Lymphatic Delineation of 211 patients for Defining the Target Volume of Perigastric Lymph Nodes in Gastric Cancer. Oncology Letters. [Accepted for publication]
    2.Wen G, et al. Management of extramedullary plasmacytoma: role of radiotherapy and prognostic factor analysis in 55 patients. Chinese Journal of Cancer Research [Accepted for publication]
    3.孟凡军,郭建贵,林尤恩,张玉晶.  71例原发颅内中枢神经系统DLBCL预后分析.  中华放射肿瘤学杂志.  2017 Vol. 26 (8): 909-913.
    4.Huang YH, Rao HL, Yan SM, Wang F, Wu QN, Feng YF, Zhang YJ*. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution. Ann Hematol. 2017 Aug; 96(8):1331-1342.(IF:3.022)
    5.Xu S, Feng L, Chen Y, Sun Y, Lu Y, Huang S, Fu Y, Zheng R*, Zhang YJ*, Zhang R*. Consistency mapping of 16 lymph node stations in gastric cancer by CT-based vessel-guided delineation of 255 patients. Oncotarget. 2017 Jun 20; 8(25): 41465- 41473. (IF:5.168)
    6.Niu SQ, Wen G, Ren YF, Li YY, Feng LL, Wang CT, Huang XB, Wen BX, Zhang YJ*. Predictive Value of Primary Tumor Site for Loco-regional Recurrence in Early Breast Cancer Patients with One to Three Positive Axillary Lymphadenophy. J Cancer. 2017; 8(12): 2394-2400.(IF:3.609).
    7.Wang QX, Li SH, Ji BY, Wang HY, Li YY, Feng LL, Chen K*, Xia YF, Zhang YJ*. Lymphocyte/Monocyte Ratio is a Novel Predictor for Early Stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type. J Cancer. 2017 Apr 8; 8(6): 1030-1037. (IF:3.609)
    8.Li YY, Lin HQ, Zhang LL, Feng LL, Niu SQ, Wang HY,  Zhang YJ*, Wang XC*. Intensity-modulated radiotherapy has superior outcomes to three-dimensional conformal radiotherapy in patients with stage IE-IIE extranodal nasal-type natural killer/T-cell lymphomatype nature killer/T-cell lymphoma. Oncotarget. 2017 Mar 11;8(36):60504-60513. (IF:5.168)
    9.Wang JH, Bi XW, Li PF, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ, Wang L. Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type. J Cancer. 2017 Feb 25;8(5):793-800. (IF:3.609)
    10.Li YY, Feng LL, Niu SQ, Wang HY, Zhang LL, Wang L, Xia ZJ, Huang HQ,  Xia YF, Zhang YJ*, Wang XC*.  Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy. Oncotarget. 2017 Feb 14; 8(7): 11480-11488. (IF:5.168)
    11.童琴,罗燕容,张玉晶*,冯玲玲,李贻阳,王汉瑜,夏云飞,艾小红.  局部区域复发的结外鼻型NK/T细胞淋巴瘤挽救治疗的疗效和预后分析. 中华放射肿瘤学杂志.  2017;26 (1):45-49.
    12.Yang Y, Cao JZ, Lan SM, Wu JX, Wu T, Zhu SY, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Xu LM, Yuan ZY, Qi SN, Li YX. Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma. JAMA Oncol.  2017 Jan 1;3(1):83-91.
    13.冯玲玲,张玉晶*,李绮雯,李贻阳,王俏镟,曾智帆,周志伟.  不能切除和复发的局部进展期胃癌放射治疗的疗效分析. 中华放射肿瘤学杂志. 2016; 25 (11): 1209-1213.
    14.Bi XW, Wang H, Zhang WW, Wang JH, Liu WJ, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ, Wang L. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma. J Hematol Oncol. 2016 Oct 13; 9(1): 109.
    15.Wang L, Bi XW, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ*. Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy. Onco Targets Ther. 2016 Sep 26; 9: 5875-5881.
    16.Wen G, Zhang JS, Zhang YJ*, Zhu YJ, Huang XB, Guan XX.   Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy. J Breast Cancer. 2016 Jun; 19(2): 176-184. (IF:1.854)
    17.温戈,张玉晶*,张金山,牛绍清,李贻阳,冯玲玲,夏云飞.  早期肺原发黏膜相关淋巴组织淋巴瘤的预后分析及文献回顾. 中华放射肿瘤学杂志.  2016; 25 (7): 713-717.
    18.Niu SQ, Yang Y, Li YY, Wen G, Wang L, Li ZM, Wang HY, Zhang LL, Xia YF, Zhang YJ*.  Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma. Chin J Cancer. 2016 Apr 4; 35(1): 34. (IF:2.814)
    19.张廷友,牛绍清,张玉晶*.  放疗在IE-IIE期胃黏膜相关淋巴组织淋巴瘤中的预后价值评价. 世界华人消化杂志.  2016; 24(6): 923-927.
    20.李贻阳,牛绍清,温戈,王俏镟,王汉渝,冯玲玲,夏云飞,张玉晶*.  基于GELOX方案诱导化疗的I-II期结外鼻型NK/T细胞淋巴瘤根治性放疗的预后分析. 中华放射肿瘤学杂志.  2016; 25 (2): 140-145.
    21.Wang L, Xia ZJ, Lu Y, Wang QX, Niu SQ, Huang HQ, Zhang YJ*.  A modified-international prognostic index including pretreatment hemoglobin level for early stage extranodal NK/T cell lymphoma. Leuk Lymphoma, 2015 Nov; 56(11): 3038-44.(SCI IF: 2.891)
    22.Wang L, Wang H, Wang JH, Xia ZJ, Lu Y, Huang HQ, Jiang WQ,  Zhang YJ*.   Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.  Oncotarget. 2015 Oct; 6(30):30317-26. (SCI IF: 6.359)
    23.Wang L, Wang Z, Xia ZJ, Lu Y, Huang HQ, Zhang YJ*. CD56 negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis. Tumour Biol. 2015 Sep; 36(10):7717-23.(SCI IF: 3.611)
    24.牛绍清,温戈,张玉晶*,王成涛,李贻阳,黄晓波,管迅行,文碧秀.  早期乳腺癌原发象限对根治术后1~3个腋窝淋巴结转移患者预后预测价值探讨.  中华放射肿瘤学杂志.  2015; 24 (5): 506-510.
    25.Yang Y, Zhu Y, Cao JZ, Zhang YJ, Xu LM, Yuan ZY, Wu JX, Wang W, Wu T, Lu B, Zhu SY, Qian LT, Zhang FQ, Hou XR, Li YX.  Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: a comprehensive analysis from a multicenter study. Blood, 2015 Sep 17;126(12):1424-1432.(SCI IF: 10.452)
    26.Wang L, Xia ZJ, Zhang YJ, Huang HQ, Lin TY, Lu Y.  Radical surgery may be not an optimal treatment approach for pulmonary MALT lymphoma. Tumour Biol. 2015 Aug; 36(8): 6409-16.  (SCI IF: 3.611)
    27.崔天祥,孙建国,张玉晶*.  三种治疗方式对早期原发胃弥漫大B细胞淋巴瘤的对比分析.  中华放射医学与防护杂志. 2015; 35(7): 514-517.
    28.Li QW, Li W, Wang L, Wang WD, Niu SQ, Bi XW, Wang HY, Zhang YJ*. Consolidation radiotherapy in stage IE-IIE, non-bulky primary gastric diffuse large B-cell lymphoma with post-chemotherapy complete remission. PLoS One. 2015, Jul 20; 10(7): e0133469.  (SCI IF: 3.234)
    29.Wang L, Wang H, Li PF, Lu Y, Xia ZJ, Huang HQ, Zhang YJ.  CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type. Ann Hematol.  2015 Aug; 94(8): 1381-8. (SCI IF: 2.634)
    30.牛绍清,张玉晶*,温戈,李贻阳,冯玲玲,王汉渝,文碧秀.  早期原发鼻腔NK/T细胞淋巴瘤局部扩大野IMRT前瞻性II期研究的初步结果. 中华放射肿瘤学杂志.  2015; 24 (4): 377-381.
    31.Yang Y, Zhang YJ*, Zhu Y, Cao JZ, Yuan ZY, Xu LM, Wu JX, Wang W, Wu T, Lu B, Zhu SY, Qian LT, Zhang FQ, Hou XR, Liu QF, Li YX.  Prognostic nomogram for overall survival in previously untreated patients with extranodal nk/t-cell lymphoma, nasal-type: a multicenter study. Leukemia. 2015 Jul; 29(7):1571-7.  (SCI IF: 10.431)
    32.Yan Z, Huang HQ, Wang XX, Gao Y, Zhang YJ, Bai B, Zhao W, Jiang WQ, Li ZM, Xia ZJ, Lin SX, Xie CM.  A TNM staging system for nasal NK/T-cell lymphoma.  PLoS One. 2015 Jun 22; 10(6): e0130984.  (SCI IF: 3.234)
    33.Wen G, Zhang JS, Chi F, Chen L, Huang SJ, Niu S, Gao YH, Wen BX, Zhang YJ*.   Dosimetric comparison study of volumetric modulated arc therapy (VMAT), 5F intensity modulated radiotherapy (IMRT) and 3D conformal radiotherapy (3DCRT) in patients with rectal carcinoma receiving neoadjuvant chemoradiotherapy.  International Journal of Medical Physics, Clinical Engineering and Radiation Oncology. 2015, 4, 54-63.  doi:10.4236/ijmpcero. 2015.41008.
    34.Li QW, Niu SQ, Wang HY, Wen G, Li YY, Xia YF, Zhang YJ*.  Radiotherapy alone is associated with improved outcomes over surgery in the management of solitary plasmacytoma. Asian Pac J Cancer Prev. 2015; 16(9):3741-5. (SCI IF: 2.514)
    35.Wang L, Xia ZJ, Lu Y, Zhang YJ*.  Prophylactic cervical lymph node irradiation provides no benefit for patients of stage IE extranodal natural killer/T cell lymphoma, nasal type.  Med Oncol. 2015 Jan; 32(1):320.  (SCI IF: 2.634)
    36.Wang L, Wu-Xiao ZJ, Chen XQ, Zhang YJ, Lu Y, Xia ZJ.  Hepatitis B virus infection correlates with poor prognosis of extranodal natural killer/T cell lymphoma. Leuk Lymphoma. 2015 Apr; 56(4):936-41. (SCI IF: 2.891)
    37.迟锋,温戈,陈利,黄思娟,张金山,牛绍清,高远红,张玉晶*.  直肠癌术前三维适形和五野及容积弧形调强放疗剂量学比较. 中华肿瘤防治杂志.  2014; 21(18): 1455-1460.
    38.Wang L, Wang WD, Xia ZJ, Zhang YJ, Xiang J, Lu Y. Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up. Med Oncol. 2014 Mar; 31(3):860. (SCI IF: 2.634)
    39.Wang L, Chi PD, Chen H, Xiang J, Xia ZJ, Zhang YJ*.  Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma. Tumour Biology. 2014 Mar; 35(3): 2141-2149. (SCI IF: 3.611)
    40.牛绍清,张玉晶*,杨勇,夏青,温戈,王汉渝,夏云飞.  早期原发鼻腔与韦氏环NK/T细胞淋巴瘤临床特征和预后比较.  中华放射肿瘤学杂志.  2013; 22 (5): 352-356.
    41.温戈,张玉晶*,祝喻甲,黄晓波,张金山,李凤岩,管迅行. 分子分型对1~3个腋窝淋巴结转移早期乳腺癌患者局部/区域复发风险的预测价值.  中华放射肿瘤学杂志.  2013; 22(2): 89-93.
    42.Wang L, Xia ZJ, Huang HQ, Lu Y, Zhang YJ*. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.  Int J Hematol. 2012 Nov; 96(5):617-623. (SCI IF: 1.918)
    43.Iyengar P, Strom EA, Zhang YJ, Whitman GJ, Smith BD, Woodward WA, Yu TK, Buchholz TA.  The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer. Oncologist. 2012; 17(11):1402-1408. (SCI IF: 4.865)
    44.Zhao X, Liu Z, Yu L, Zhang Y, Baxter P, Voicu H, Gurusiddappa S, Luan J, Su JM, Leung HC, Li XN. Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma.  Neuro Oncol.  2012; 14(5):574-583. (SCI IF: 5.562)
    45.杨勇,张玉晶*,孙颖,高远红,黄莹,刘孟忠,夏云飞. 18例早期结外鼻型NK/T细胞淋巴瘤同期放化疗疗效分析.  中华肿瘤防治杂志. 2012, 19(5):378-381.
    46.Cai L, Stauder MC, Zhang YJ, Poortmans P, Li YX, Constantinou N, Thariat J, Kadish SP, Nguyen TD, Kirova YM, Ghadjar P, Weber DC, Bertran VT, Ozsahin M, Mirimanoff RO. Early-Stage Primary Bone Lymphoma: A Retrospective, Multicenter Rare Cancer Network (RCN) Study. Int J Radiat Oncol Biol Phys. 2012; 83(1): 284-291. (SCI IF: 4.258)
    47.温戈,黄晓波,张玉晶*,陈利,高远红,胡永红,刘孟忠.  早期原发胃淋巴瘤三维适形放疗剂量优化研究. 中国肿瘤临床.  2011; 38(14): 855-858.
    48.温戈,王汉渝,张玉晶*,蔡玲,杨勇,夏云飞,管迅行,刘孟忠.  原发性骨淋巴瘤的疗效和预后因素分析. 中华放射肿瘤学杂志.  2011; 20(4): 313-316.
    49.Yu L, Baxter PA, Zhao X, Liu Z, Wadhwa L, Zhang Y, Su JM, Tan X, Yang J, Adesina A, Perlaky L, Hurwitz M, Idamakanti N, Police SR, Hallenbeck PL, Blaney SM, Chintagumpala M, Hurwitz RL, Li XN. A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models. Neuro Oncol. 2011; 13(1): 14-27. (SCI IF: 5.562)
    50.杨 勇,陈利,张玉晶*,温戈,黄晓波,李凤岩,林焕新,胡永红,刘孟忠,管迅行. 乳腺癌辅助放射治疗内乳区电子线野结合胸壁切线野的剂量学研究. 中华放射医学与防护杂志.  2010; 30(6): 104-106.
    51.Zhang YJ, Oh JL, Whitman GJ, Iyengar P, Yu TK, Tereffe W, Woodward WA, Perkins G, Buchholz TA, Strom EA. Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control. Int J Radiat Oncol Biol Phys. 2010; 77(4): 1113-1119. (SCI IF: 4.258)
    52.Yu L, Baxter PA, Voicu H, Gurusiddappa S, Zhao Y, Adesina A, Man TK, Shu Q, Zhang YJ, Zhao XM, Su JM, Perlaky L, Dauser R, Chintagumpala M, Lau CC, Blaney SM, Rao PH, Leung HC, Li XN. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol. 2010; 12(6): 580-594.

    近年国际会议摘要:
    1.Wen B, Niu S, Wang C, Zhang Y.  Predictive Value of Primary Tumor Site for Locoregional Recurrence in Early Breast Cancer Patients With 1 to 3 Positive Axillary Lymphadenophy. Int J Radiat Oncol Biol Phys, Proceedings of the 58th Annual ASTRO Meeting, 2016, 96 (2 suppl): E25-E26.
    2.Zhang YJ, Yang Y, Chen L, Wen G, Huang XB, Li FY, Lin HX, Hu YH, Guan XX.  Addition of Internal Mammary Electron Beam Field to Inner Tangential Photon Field Improves Conformality of Adjuvant Chest Wall Radiotherapy Planning for Patients with Breast Cancer. International Breast Cancer Conference 2011, Hongkong, Prize of Best Poster.
    3.Zhang YJ, Li JS, Yang Y, Zou GR, Xie FY, Wang HY, Xia YF. Prognosis Comparison and Therapeutic Considerations Between Primary Nasopharyngeal B- and T/NK-cell Non-Hodgkin's Lymphomas at Early Stage: A Study of 136 Cases in South China.  Int J Radiat Oncol Biol Phys, Proceedings of the 52nd Annual ASTRO Meeting, 2010, 78 (3 suppl): S555.
    4.Yang Y, Zhang YJ, Lin XB, Wang JJ, Lin SX, Li Q, Xia YF, Guan XX, Lin TY.  Role of Radiotherapy and Prognosis Analyses in Patients with Early Stage Extranodal Nasal Type NK/T-cell Lymphoma Treated Predominantly with Initial Chemotherapy. Int J Radiat Oncol Biol Phys, Proceedings of the 52nd Annual ASTRO Meeting, 2010, 78 (3 suppl): S548.
    5.Cai L, Stauder MC, Zhang YJ, Poortmans P, Li YX, Constantinou N, Thariat J, Kadish S, Ozsahin M, Mirimanoff RO. Early Stage Primary Bone Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study. Int J Radiat Oncol Biol Phys, Proceedings of the 52nd Annual ASTRO Meeting, 2010, 78 (3 suppl): S84.
    6.Iyengar P, Strom EA, Zhang YJ, Whitman GJ, Woodward WA, Yu T-K, Buchholz TA. Locally advanced breast cancer frequently involves the extra-axillary regional nodes: Incidence and treatment impact. Cancer Res, 2009; 69(suppl): 257S.
     
    近年编著和翻译:
    1.张玉晶. 副主编. 见 龙浩. 主编. 乳腺癌内乳淋巴结研究. 广东科技出版社,2015.8.
    2.张玉晶. 肛管癌放射治疗.  见 王天宝,尉秀清,崔言刚,任军. 主编. 实用胃肠恶性肿瘤诊疗学. 广州, 广东科技出版社, 2012;pp 273-277.
    3.张玉晶,高远红,李鹤平. 胃癌淋巴转移的放射治疗. 见 何裕隆,主编. 胃癌淋巴转移.  北京,人民卫生出版社,2010;pp 305-319.

    专家门诊时间: 周一下午(特需)、周四上午(专家)


    更新时间:2017年10月25日

访客通道
员工通道
关注肿瘤医院
留言建议 ×